Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urokinase-Type Plasminogen Activator | 18 | 2000 | 340 | 0.990 |
Why?
|
| Pulmonary Embolism | 48 | 2005 | 2397 | 0.780 |
Why?
|
| Thrombolytic Therapy | 10 | 2009 | 2182 | 0.630 |
Why?
|
| Fibrinolytic Agents | 23 | 2001 | 2139 | 0.580 |
Why?
|
| Streptokinase | 12 | 2000 | 189 | 0.400 |
Why?
|
| Publications | 1 | 2011 | 209 | 0.360 |
Why?
|
| Heparin | 21 | 2003 | 1637 | 0.330 |
Why?
|
| Hemodynamics | 19 | 2009 | 4231 | 0.280 |
Why?
|
| Scleroderma, Systemic | 1 | 2009 | 302 | 0.280 |
Why?
|
| Venous Thromboembolism | 5 | 2011 | 1580 | 0.260 |
Why?
|
| Thrombophlebitis | 10 | 1992 | 313 | 0.260 |
Why?
|
| Secondary Prevention | 2 | 2009 | 1515 | 0.240 |
Why?
|
| Thrombosis | 4 | 2011 | 2860 | 0.220 |
Why?
|
| Hypertension, Pulmonary | 5 | 2009 | 1502 | 0.210 |
Why?
|
| Plasminogen Activators | 2 | 1998 | 218 | 0.190 |
Why?
|
| Arterial Occlusive Diseases | 3 | 1998 | 812 | 0.170 |
Why?
|
| Thromboembolism | 4 | 2001 | 986 | 0.150 |
Why?
|
| Leg | 4 | 1998 | 1139 | 0.150 |
Why?
|
| Radionuclide Imaging | 18 | 1989 | 2037 | 0.150 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2008 | 328 | 0.140 |
Why?
|
| Platelet Factor 4 | 2 | 1988 | 127 | 0.140 |
Why?
|
| Anticoagulants | 8 | 2016 | 4373 | 0.130 |
Why?
|
| Enzyme Precursors | 1 | 1994 | 186 | 0.130 |
Why?
|
| Hemorrhage | 9 | 2016 | 3276 | 0.120 |
Why?
|
| Pulmonary Circulation | 10 | 1986 | 736 | 0.120 |
Why?
|
| Enoxaparin | 2 | 2005 | 363 | 0.110 |
Why?
|
| Peripheral Vascular Diseases | 1 | 1996 | 583 | 0.110 |
Why?
|
| beta-Thromboglobulin | 2 | 1988 | 24 | 0.100 |
Why?
|
| Organizations | 1 | 2011 | 164 | 0.100 |
Why?
|
| Angiography | 14 | 1986 | 1669 | 0.100 |
Why?
|
| Plethysmography, Impedance | 5 | 1983 | 43 | 0.100 |
Why?
|
| Dihydroergotamine | 1 | 1988 | 18 | 0.090 |
Why?
|
| Myocardial Infarction | 5 | 1995 | 11423 | 0.080 |
Why?
|
| Recombinant Proteins | 5 | 2007 | 6860 | 0.080 |
Why?
|
| Blood Specimen Collection | 1 | 1988 | 247 | 0.080 |
Why?
|
| Factor VII | 1 | 2007 | 146 | 0.080 |
Why?
|
| Acute Disease | 8 | 2005 | 7177 | 0.070 |
Why?
|
| Plasminogen | 4 | 1992 | 151 | 0.070 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1977 | 318 | 0.070 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 1008 | 0.060 |
Why?
|
| Isoproterenol | 1 | 1984 | 414 | 0.060 |
Why?
|
| Pulmonary Artery | 13 | 1984 | 1901 | 0.060 |
Why?
|
| Humans | 71 | 2016 | 717237 | 0.060 |
Why?
|
| Blood Volume | 2 | 1982 | 587 | 0.060 |
Why?
|
| Drugs, Generic | 1 | 2008 | 487 | 0.050 |
Why?
|
| Blood Pressure | 13 | 2000 | 8583 | 0.050 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 910 | 0.050 |
Why?
|
| Disease Management | 2 | 2009 | 2537 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 1983 | 370 | 0.050 |
Why?
|
| Lung | 10 | 1989 | 9781 | 0.050 |
Why?
|
| Vascular Resistance | 4 | 2000 | 958 | 0.050 |
Why?
|
| Cardiac Output | 7 | 1984 | 906 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2001 | 261 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 1995 | 1652 | 0.040 |
Why?
|
| Blood Coagulation Tests | 2 | 1994 | 268 | 0.040 |
Why?
|
| Electrocardiography | 13 | 1989 | 6409 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1996 | 11276 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 1982 | 700 | 0.040 |
Why?
|
| Microcirculation | 4 | 1986 | 1302 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 4531 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 1982 | 1011 | 0.040 |
Why?
|
| Aspirin | 3 | 1994 | 3169 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2005 | 5038 | 0.040 |
Why?
|
| Dextrans | 1 | 1979 | 617 | 0.040 |
Why?
|
| Phlebography | 4 | 1983 | 323 | 0.040 |
Why?
|
| Postoperative Complications | 5 | 2009 | 15126 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4636 | 0.040 |
Why?
|
| Infusions, Parenteral | 3 | 1982 | 431 | 0.040 |
Why?
|
| Hospitalization | 3 | 2009 | 9754 | 0.040 |
Why?
|
| Radiography | 10 | 1989 | 7001 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 1979 | 410 | 0.030 |
Why?
|
| Venous Thrombosis | 2 | 2003 | 1242 | 0.030 |
Why?
|
| Embolism | 1 | 1998 | 382 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 1982 | 1403 | 0.030 |
Why?
|
| Middle Aged | 21 | 2005 | 215041 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2007 | 2416 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9512 | 0.030 |
Why?
|
| Recurrence | 3 | 2000 | 8282 | 0.030 |
Why?
|
| Heart Ventricles | 6 | 1984 | 3837 | 0.030 |
Why?
|
| Exercise Test | 1 | 2000 | 2119 | 0.030 |
Why?
|
| Vascular Patency | 1 | 1994 | 907 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7486 | 0.030 |
Why?
|
| Endopeptidases | 1 | 1975 | 844 | 0.030 |
Why?
|
| Dogs | 5 | 1991 | 4046 | 0.030 |
Why?
|
| Pulmonary Heart Disease | 3 | 1984 | 40 | 0.030 |
Why?
|
| Drug Evaluation | 2 | 1982 | 660 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2016 | 987 | 0.020 |
Why?
|
| Male | 22 | 2005 | 351380 | 0.020 |
Why?
|
| Time Factors | 5 | 2000 | 41095 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1973 | 686 | 0.020 |
Why?
|
| Capillaries | 2 | 1984 | 781 | 0.020 |
Why?
|
| Clinical Trials as Topic | 5 | 1988 | 8013 | 0.020 |
Why?
|
| Heart Diseases | 3 | 1977 | 2762 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 3565 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 1996 | 6528 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 1996 | 11910 | 0.020 |
Why?
|
| Fibrinolysis | 2 | 1986 | 346 | 0.020 |
Why?
|
| Aged | 15 | 2003 | 162856 | 0.020 |
Why?
|
| Echocardiography | 1 | 1980 | 5099 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 956 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2016 | 1070 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 1987 | 156 | 0.020 |
Why?
|
| Female | 14 | 2005 | 377909 | 0.020 |
Why?
|
| Ischemia | 1 | 1996 | 1955 | 0.020 |
Why?
|
| Oxygen | 6 | 1984 | 4179 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 1971 | 596 | 0.020 |
Why?
|
| Myocardium | 3 | 1980 | 4943 | 0.020 |
Why?
|
| Risk | 2 | 1998 | 9773 | 0.020 |
Why?
|
| Vena Cava, Inferior | 1 | 1969 | 449 | 0.020 |
Why?
|
| Survival Rate | 1 | 2000 | 13261 | 0.020 |
Why?
|
| Heart | 3 | 1974 | 4332 | 0.020 |
Why?
|
| Survival Analysis | 1 | 1998 | 10542 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 39302 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 1988 | 362 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2016 | 2035 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 3 | 1977 | 364 | 0.020 |
Why?
|
| Lung Diseases | 3 | 1984 | 1895 | 0.020 |
Why?
|
| Adult | 16 | 2003 | 212451 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2008 | 1423 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1983 | 154 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 2 | 1972 | 39 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2456 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2009 | 1208 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 62348 | 0.010 |
Why?
|
| Prospective Studies | 3 | 1996 | 51275 | 0.010 |
Why?
|
| Xenon | 2 | 1973 | 113 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1994 | 4419 | 0.010 |
Why?
|
| Lidoflazine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1995 | 8066 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1988 | 1942 | 0.010 |
Why?
|
| Technetium | 2 | 1972 | 355 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1984 | 3963 | 0.010 |
Why?
|
| Nifedipine | 1 | 1982 | 221 | 0.010 |
Why?
|
| Diltiazem | 1 | 1982 | 136 | 0.010 |
Why?
|
| Verapamil | 1 | 1982 | 254 | 0.010 |
Why?
|
| Prognosis | 3 | 2016 | 29226 | 0.010 |
Why?
|
| Kinins | 1 | 1980 | 25 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 1984 | 14381 | 0.010 |
Why?
|
| Diagnosis, Differential | 5 | 1977 | 13274 | 0.010 |
Why?
|
| Fibrinogen | 3 | 1976 | 915 | 0.010 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1980 | 92 | 0.010 |
Why?
|
| Heart Aneurysm | 1 | 1980 | 123 | 0.010 |
Why?
|
| Coronary Disease | 2 | 1988 | 6127 | 0.010 |
Why?
|
| Papillary Muscles | 1 | 1980 | 199 | 0.010 |
Why?
|
| Platelet Count | 1 | 1983 | 797 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1141 | 0.010 |
Why?
|
| Captopril | 1 | 1980 | 273 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 14243 | 0.010 |
Why?
|
| Respiration | 1 | 1966 | 1671 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1983 | 809 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1991 | 1476 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1980 | 432 | 0.010 |
Why?
|
| Pain | 2 | 1977 | 4692 | 0.010 |
Why?
|
| Clothing | 1 | 1979 | 93 | 0.010 |
Why?
|
| Proline | 1 | 1980 | 440 | 0.010 |
Why?
|
| Risk Factors | 3 | 2016 | 70864 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 18738 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 1980 | 482 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1991 | 5160 | 0.010 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2003 | 576 | 0.010 |
Why?
|
| Joint Prosthesis | 1 | 1979 | 253 | 0.010 |
Why?
|
| Coronary Vessels | 2 | 1982 | 2988 | 0.010 |
Why?
|
| Warfarin | 1 | 2005 | 1457 | 0.010 |
Why?
|
| Angiotensin II | 1 | 1980 | 921 | 0.010 |
Why?
|
| Partial Pressure | 2 | 1975 | 260 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1967 | 400 | 0.010 |
Why?
|
| Aldosterone | 1 | 1980 | 816 | 0.010 |
Why?
|
| Pressure | 1 | 1979 | 1240 | 0.010 |
Why?
|
| Hemoptysis | 1 | 1977 | 151 | 0.010 |
Why?
|
| Thrombectomy | 1 | 2001 | 683 | 0.010 |
Why?
|
| Pleura | 1 | 1977 | 231 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 1649 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2005 | 2752 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1974 | 123 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1974 | 211 | 0.010 |
Why?
|
| Tachycardia | 1 | 1977 | 609 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2016 | 23542 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17432 | 0.010 |
Why?
|
| Incidence | 1 | 1992 | 20653 | 0.010 |
Why?
|
| Regional Blood Flow | 2 | 1974 | 1568 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1982 | 9047 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1977 | 341 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 1974 | 334 | 0.010 |
Why?
|
| Snakes | 1 | 1973 | 29 | 0.010 |
Why?
|
| Cineangiography | 1 | 1972 | 127 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2003 | 4921 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1973 | 118 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 1972 | 198 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1979 | 625 | 0.010 |
Why?
|
| Neurosurgery | 1 | 1979 | 635 | 0.010 |
Why?
|
| Venoms | 1 | 1973 | 96 | 0.010 |
Why?
|
| Hip Joint | 1 | 1979 | 949 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1979 | 1512 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1974 | 616 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1981 | 868 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18798 | 0.010 |
Why?
|
| Respiratory Function Tests | 3 | 1972 | 1671 | 0.010 |
Why?
|
| Microspheres | 1 | 1974 | 800 | 0.010 |
Why?
|
| alpha-Macroglobulins | 1 | 1991 | 65 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1984 | 4589 | 0.010 |
Why?
|
| Radioisotopes | 1 | 1973 | 501 | 0.010 |
Why?
|
| Fibrinolysin | 1 | 1991 | 136 | 0.010 |
Why?
|
| Cardiac Volume | 1 | 1971 | 212 | 0.010 |
Why?
|
| Heart Rate | 2 | 1971 | 4100 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 1977 | 1346 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1972 | 682 | 0.010 |
Why?
|
| Length of Stay | 1 | 2003 | 6280 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 1980 | 1831 | 0.010 |
Why?
|
| Cough | 1 | 1973 | 564 | 0.010 |
Why?
|
| Iliac Vein | 1 | 1969 | 74 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1975 | 1666 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 2001 | 1877 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1973 | 1669 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1969 | 162 | 0.010 |
Why?
|
| Posture | 1 | 1972 | 993 | 0.010 |
Why?
|
| Spinal Cord Injuries | 1 | 1976 | 992 | 0.010 |
Why?
|
| United States | 2 | 1992 | 67798 | 0.010 |
Why?
|
| Pneumoconiosis | 1 | 1966 | 36 | 0.000 |
Why?
|
| Perfusion | 1 | 1971 | 1276 | 0.000 |
Why?
|
| Femoral Artery | 1 | 1991 | 922 | 0.000 |
Why?
|
| Research Design | 1 | 1982 | 5883 | 0.000 |
Why?
|
| Dyspnea | 1 | 1973 | 1256 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1973 | 1144 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1975 | 6542 | 0.000 |
Why?
|
| Animals | 5 | 1991 | 170890 | 0.000 |
Why?
|
| Disease Models, Animal | 2 | 1991 | 18352 | 0.000 |
Why?
|
| Carbon | 1 | 1966 | 654 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1988 | 58528 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1967 | 1115 | 0.000 |
Why?
|
| Pneumonia | 1 | 1973 | 2102 | 0.000 |
Why?
|
| Heart Failure | 2 | 1975 | 10185 | 0.000 |
Why?
|
| Hydrochlorothiazide | 1 | 1980 | 109 | 0.000 |
Why?
|
| Pregnancy | 1 | 2001 | 27306 | 0.000 |
Why?
|
| Contrast Media | 1 | 1972 | 5278 | 0.000 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1980 | 273 | 0.000 |
Why?
|
| Renin | 1 | 1980 | 620 | 0.000 |
Why?
|
| Heart Atria | 2 | 1975 | 1273 | 0.000 |
Why?
|
| Dilatation | 1 | 1975 | 266 | 0.000 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1980 | 1482 | 0.000 |
Why?
|
| Bundle-Branch Block | 1 | 1975 | 276 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1976 | 1029 | 0.000 |
Why?
|
| Cardiomegaly | 1 | 1975 | 650 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1972 | 444 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1972 | 411 | 0.000 |
Why?
|
| Heart Conduction System | 1 | 1972 | 1032 | 0.000 |
Why?
|
| Occupations | 1 | 1966 | 511 | 0.000 |
Why?
|
| Hypertension | 1 | 1980 | 8286 | 0.000 |
Why?
|
Concepts
(247)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_